Ultrasonic treatment patch for interior of human body

Abstract

The invention relates to an ultrasonic treatment patch for the interior of a human body. The ultrasonic treatment patch comprises a biological material bottom layer membrane, a biological material surface layer membrane and a miniature ultrasonic vibration module arranged between the biological material bottom layer membrane and the biological material surface layer membrane in a wrapping mode. Due to the characteristics of the biological material, the ultrasonic treatment patch can be safely used in a human body, so that the ultrasonic treatment patch can be directly attached to a diseased region, the diseased region is directly subjected to ultrasonic treatment, ultrasonic waves can directly reach the diseased region, pathological tissue cells are ensured to be killed, and the ultrasonic waves do not need to pass through the skin of the human body; the influence of ultrasonic waves on human skin is greatly reduced; meanwhile, the miniature ultrasonic vibration module can perform ultrasonic vibration work, has a wireless charging function and a wireless control function, and can be used in a human body for a long time only by one-time implantation, so that a patient can be subjected to ultrasonic treatment regularly at home and does not need to go to and go back to a hospital frequently; and the number of times and the time and money cost for the patient to go back and forth to the hospital are greatly reduced.

Description

Technical Field

[0001] The invention relates to the field of human ultrasonic wave treatment instruments, in particular to an ultrasonic wave treatment patch for the inside of the human body. Background Art

[0002] Ultrasonic therapy devices use ultrasound as a treatment source, focusing ultrasound outside the body on the diseased tissue inside the body, causing the temperature of the diseased tissue inside the body to rise rapidly. Under the mechanical effect, thermal penetration and cavitation, biological effects are produced, thereby destroying the structure of diseased tissue cells, causing diseased tissue cells to necrotize. It can also promote blood circulation, accelerate metabolism, and regenerate healthy tissue, thereby achieving the purpose of treating diseased tissue.

[0003] In the existing ultrasonic therapeutic devices, for example, a technical solution named "A real-time positioning low-energy ultrasonic therapeutic device" is disclosed in Chinese patent literature with patent application number 202010504927.4. The solution mainly includes a therapeutic device host and an ultrasonic probe, wherein the therapeutic device host is composed of a supporting device, a control panel, an image display screen, and an ultrasonic generating device, and the ultrasonic probe is connected to the ultrasonic generating device. During treatment, medical staff places the ultrasonic probe on the surface of the human body, so that the ultrasonic probe can output ultrasonic waves to the human body and perform ultrasonic treatment on the lesion. However, in actual applications, this type of ultrasonic therapeutic device still has the following shortcomings: First, these ultrasonic therapeutic devices are all external therapeutic devices. Ultrasonic waves need to pass through human skin tissue before reaching the lesion site, and cannot reach the affected area directly. In addition, skin tissue will absorb part of the ultrasonic energy, which weakens the ultrasonic energy reaching the lesion site, resulting in reduced destructive power to the lesion tissue cells, which in turn leads to slow therapeutic effect. If the energy intensity of the ultrasonic wave is increased, although it can ensure that the lesion tissue cells are killed, it will also damage the skin tissue cells, and there will be a large side effect problem. This method of increasing the ultrasonic energy intensity is not advisable.

[0004] Second, this type of ultrasonic therapeutic device requires professional medical staff in the hospital to know how to operate it. Patients can only go back and forth to the hospital frequently for regular treatment, and the time and money costs are also very high.

[0005] Therefore, the applicant believes that it is very necessary to design an ultrasonic therapeutic patch for the human body that can be implanted inside the human body, directly treat the affected area, and can be used for regular treatment without frequent trips to the hospital. Summary of the invention

[0006] The object of the present invention is to solve the above-mentioned problems and shortcomings and to provide an ultrasonic therapeutic patch for internal human body. The biomaterial characteristics of the ultrasonic therapeutic patch for internal human body enable the ultrasonic therapeutic patch to be safely used in the human body, so that it can be directly applied to the diseased part and ultrasonic treatment can be directly performed on the diseased part, so that the ultrasonic wave can directly reach the affected part to ensure that the diseased tissue cells are killed, and the ultrasonic wave does not need to pass through the human skin, thereby greatly reducing the impact of the ultrasonic wave on the human skin; at the same time, the micro ultrasonic vibration module can not only perform ultrasonic vibration work, but also has wireless charging function and wireless control function. It only needs to be implanted once and can be used for a long time in the human body, so that the patient can regularly perform ultrasonic treatment at home without frequent travel to and from the hospital, thereby greatly reducing the number of times the patient travels to and from the hospital and the time and money costs.

[0007] The technical solution of the present invention is implemented as follows: an ultrasonic therapeutic patch for internal human body, characterized in that it includes a biomaterial bottom diaphragm and a biomaterial surface diaphragm stacked together, and a micro-ultrasonic vibration module coated between the biomaterial bottom diaphragm and the biomaterial surface diaphragm; the micro-ultrasonic vibration module includes a bottom shell and a shell cover with a accommodating cavity and assembled together, and an ultrasonic vibration component and a drive control component arranged in the accommodating cavity; the ultrasonic vibration component includes a sliding block with a permanent magnet block, a spring arranged at both ends of the sliding block for buffering and rebounding, and a drive coil that cooperates with the permanent magnet block to produce a magnetic drive effect; the drive control component includes a circuit board with a wireless communication module, a battery electrically connected to the circuit board, and a wireless charging coil, and the drive coil is electrically connected to the circuit board to drive the ultrasonic vibration component to work.

[0008] Preferably, the accommodating chamber is provided with a partition sheet for dividing the accommodating chamber into a first working chamber and a second working chamber; the ultrasonic vibration component is arranged in the first working chamber, and the drive control component is arranged in the second working chamber.

[0009] Preferably, the second working chamber and the first working chamber are stacked up and down.

[0010] Preferably, the driving coil is arranged on the partition sheet, and the sliding block is arranged on the shell cover.

[0011] Preferably, sensors electrically connected to the circuit board are respectively provided at both ends of the bottom shell.

[0012] Preferably, transition slopes are also provided on the four sides of the bottom shell.

[0013] Preferably, the biomaterial bottom layer membrane and the biomaterial surface layer membrane are respectively provided with a plurality of ventilation holes.

[0014] Preferably, an adhesive layer is further provided on the bottom surface of the biomaterial bottom layer membrane, and a release paper is further provided on the bottom surface of the adhesive layer.

[0015] Beneficial effects of the present invention: Since the present invention uses a biomaterial bottom membrane and a biomaterial surface membrane that are stacked together, and a micro-ultrasonic vibration module that is coated between the biomaterial bottom membrane and the biomaterial surface membrane; its biomaterial characteristics make the ultrasonic treatment patch of the present invention have good biocompatibility, no foreign body sensation, no adverse reactions, and can be safely used in the human body after being implanted in the human body. Through such a structural design, the ultrasonic treatment patch of the present invention can be directly applied to the lesion site, and ultrasonic treatment can be directly performed on the lesion site, so that the ultrasonic wave can directly reach the affected area, ensuring that the ultrasonic wave energy is not weakened, and ensuring that the lesion tissue cells are killed; And when using ultrasound The ultrasonic cavitation effect can promote blood circulation, relieve soft tissue, reduce swelling and inflammation, and improve tissue nutrition. It can destroy blood clots, ablate the formation of blood clots, and help the inner wall of blood vessels to repair themselves. . In addition, ultrasound waves do not need to pass through human skin, which can greatly reduce the impact of ultrasound waves on human skin. At the same time, the micro-ultrasonic vibration module of the present invention is provided with a driving control component, which can not only drive the ultrasonic vibration component to work, but also has wireless charging and wireless control functions. In this way, the ultrasonic treatment patch can be used for a long time inside the human body with only one implant, and professional medical staff can set the parameters of ultrasonic energy intensity and working time in the circuit board, so that patients can also receive regular ultrasonic treatment at home without frequent trips to the hospital, which greatly reduces the number of trips to the hospital and the time and money costs. at the same time It can also significantly reduce the amount of drugs patients take, greatly reducing the harm to human health caused by drug side effects, which is beneficial To extend people's lifespan. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 It is a schematic diagram of the overall structure of the present invention.

[0017] Figure 2 For the present invention Figure 1 Schematic diagram of the cross-sectional structure of the AA section.

[0018] Figure 3 It is a schematic diagram of the split structure of the present invention.

[0019] Figure 4 It is a schematic diagram of the three-dimensional structure of the release paper and the biomaterial bottom film in the present invention.

[0020] Figure 5 It is a schematic diagram of the three-dimensional structure of the micro ultrasonic vibration module in the present invention.

[0021] Figure 6 This is one of the schematic diagrams of the disassembled structure of the micro ultrasonic vibration module in the present invention.

[0022] Figure 7This is the second schematic diagram of the disassembled structure of the micro ultrasonic vibration module in the present invention.

[0023] Figure 8 It is a schematic diagram of the cross-sectional structure of the bottom shell, the partition piece and the shell cover in the present invention.

[0024] Fig. 9 This is a schematic diagram of the use state of the present invention when charging. DETAILED DESCRIPTION

[0025] like Figure 1 and Figure 2 As shown, the ultrasonic patch for internal human body treatment of the present invention comprises a biomaterial bottom film sheet 1 and a biomaterial surface film sheet 2 stacked together, and a micro ultrasonic vibration module 3 coated between the biomaterial bottom film sheet 1 and the biomaterial surface film sheet 2; Figures 5 to 7 As shown, the micro ultrasonic vibration module 3 includes a bottom shell 32 and a shell cover 35 with a accommodating cavity 31 and assembled together, and an ultrasonic vibration component 33 and a drive control component 34 arranged in the accommodating cavity 31; the ultrasonic vibration component 33 includes a sliding block 332 with a permanent magnet block 331, shrapnel 333 arranged at both ends of the sliding block 332 for buffering and rebounding, and a drive coil 334 that cooperates with the permanent magnet block 331 to generate a magnetic drive effect; the drive control component 34 includes a circuit board 342 with a wireless communication module 341, a battery 343 and a wireless charging coil 344 electrically connected to the circuit board 342, and the drive coil 334 is electrically connected to the circuit board 342 to drive the ultrasonic vibration component 33 to work.

[0026] The working principle of the ultrasonic vibration component 33: the battery 343 supplies power to the driving coil 334 through the circuit board 342. The current flows into the driving coil 334 to generate a magnetic field, driving the permanent magnet block 331 and the sliding block 332 to reciprocate, thereby generating high-frequency vibrations. These high-frequency vibrations propagate in media such as gas, liquid, and solid to form ultrasonic waves.

[0027] Compared with the traditional eccentric motor, the structural design of the ultrasonic vibration component 33 reduces the inertia of movement, can achieve rapid start and stop, and does not need to leave space for eccentric rotation, so that the overall thickness of the micro ultrasonic vibration module 3 can be made thinner. And through the setting of the wireless communication module 341, the user can send an opening and closing signal to the wireless communication module 341 through a wireless communication device, so that the circuit board 342 controls the start and stop of the entire ultrasonic vibration component 33. The wireless communication module 341 is an ultra-micro Bluetooth communication module or a WiFi communication module. The module can be connected to a computer, a smart phone, a tablet computer and other devices to control the micro ultrasonic vibration module 3. Monitoring, data transmission, etc.

[0028] In practical applications, the biomaterial bottom layer membrane 1 and the biomaterial surface layer membrane 2 are made of electronic skin films with good air permeability such as silk protein-based electronic skin PBES, or silk cellulose and polyurethane SF-PU composite film, or silk protein composite membrane SFCM.

[0029] In actual applications, the driving coil 334 , the wireless charging coil 344 and the battery 343 are all electrically connected to the circuit board 342 through wires, and the wireless communication module 341 is built into the circuit board 342 .

[0030] Specifically, the accommodating cavity 31 may be disposed on the bottom shell 32 or on the shell cover 35 .

[0031] like Figures 5 to 8 As shown, the accommodating chamber 31 is provided with a partition sheet 36 for dividing the accommodating chamber 31 into a first working chamber 311 and a second working chamber 312; the ultrasonic vibration component 33 is arranged in the first working chamber 311, and the drive control component 34 is arranged in the second working chamber 312. By dividing the accommodating chamber 31 into two independent chambers, the ultrasonic vibration component 33 and the drive control component 34 will not interfere with each other, so that the work of the two is more stable and reliable.

[0032] like Figures 6 to 9 As shown, the second working chamber 312 and the first working chamber 311 are stacked up and down. In this way, the ultrasonic vibration component 33 can be arranged along the length direction of the micro ultrasonic vibration module 3, so that the vibration frequency of each part of the micro ultrasonic vibration module 3 is more balanced, and the ultrasonic vibration treatment effect is better. And by locating the second working chamber 312 above the first working chamber 311, the wireless charging coil 344 can be closer to the top surface of the bottom shell 32, so that the wireless charging coil 344, as the receiving end of the wireless charging device, can be closer to the transmitting end 100 of the external wireless charging device, thereby making the wireless transmission of electric energy more stable, reliable, and not easy to interrupt. In addition to using the ultrasonic vibration component described above as an embodiment of the present invention In addition, ultrasonic transducers and ultrasonic vibration motors can also be used as an alternative. The performance is slightly worse when using an ultrasonic vibration motor.

[0033] like Figure 6 As shown, the driving coil 334 is arranged on the partition sheet 36, and the sliding block 332 is arranged on the shell cover 35. In this way, there is no need to move the wires out to the shell cover 35, which can improve the convenience of assembly and prevent the wires from affecting the sliding of the sliding block 332.

[0034] like Figure 3As shown, the two ends of the bottom shell 32 are also provided with sensors 4 electrically connected to the circuit board 342. The sensor 4 can be a heart rate detection sensor, a blood oxygen detection sensor, a body temperature detection sensor, or an image sensor with a micro camera, etc., which can facilitate the detection and observation of human health conditions to increase the use function of the ultrasonic treatment patch. When an image sensor with a micro camera is used, the biomaterial bottom film 1 or the biomaterial surface film 2 is also provided with anti-shielding perforations 21 corresponding to the two micro cameras.

[0035] like Fig. 9 As shown, the bottom shell 32 is also provided with transition slopes 321 on the sides thereof. In this way, after the micro ultrasonic vibration module 3 is coated, no overly sharp corners and edges are formed on the biomaterial bottom membrane 1 and the biomaterial surface membrane 2, so that after the ultrasonic treatment patch is implanted in the human body, no obvious discomfort is generated.

[0036] like Figure 3 As shown, the biomaterial bottom film 1 and the biomaterial surface film 2 are respectively provided with a plurality of ventilation holes 20. This can further improve the air permeability, and after being implanted in the human body, it can also provide blood circulation, so as to better adapt to the operation of the internal structure of the human body and reduce the adverse effects on the human body.

[0037] like Figure 2 and Figure 4 As shown, an adhesive layer 5 is also provided on the bottom surface of the biomaterial bottom film 1, and a release paper 6 is also provided on the bottom surface of the adhesive layer 5. This can increase the connection stability between the ultrasonic treatment patch and the lesion part of the human body, so that the ultrasonic treatment patch will not shift, and ensure the accuracy of the ultrasonic wave reaching the affected part. By providing the release paper 6, the adhesive layer 5 is not easily contaminated by other impurities, ensuring hygiene. In practical applications, the adhesive layer 5 is composed of the existing common and commonly used WAB bioadhesive. In addition to using adhesive layers to fix, you can also use the suture method currently used in medical treatment. Fix the product to the diseased part of the human body with sutures.

Claims

1. An ultrasonic treatment patch for human body, characterized in that: It comprises a biomaterial bottom membrane (1) and a biomaterial surface membrane (2) which are stacked together, and a micro ultrasonic vibration module (3) which is coated between the biomaterial bottom membrane (1) and the biomaterial surface membrane (2); The micro ultrasonic vibration module (3) comprises a bottom shell (32) and a shell cover (35) which are assembled together and have a receiving cavity (31), and an ultrasonic vibration component (33) and a drive control component (34) which are arranged in the receiving cavity (31); The ultrasonic vibration component (33) comprises a sliding block (332) with a permanent magnet block (331), spring sheets (333) arranged at both ends of the sliding block (332) for buffering and rebounding, and a driving coil (334) that cooperates with the permanent magnet block (331) to generate a magnetic driving effect; The drive control component (34) comprises a circuit board (342) with a wireless communication module (341), a battery (343) electrically connected to the circuit board (342), and a wireless charging coil (344); the drive coil (334) is electrically connected to the circuit board (342) to drive the ultrasonic vibration component (33) to operate.

2. The ultrasonic patch for internal human body treatment according to claim 1, characterized in that: The accommodating chamber (31) is provided with a partition sheet (36) for dividing the accommodating chamber (31) into a first working chamber (311) and a second working chamber (312); the ultrasonic vibration component (33) is arranged in the first working chamber (311), and the drive control component (34) is arranged in the second working chamber (312).

3. The ultrasonic patch for internal human body treatment according to claim 2, characterized in that: The second working chamber (312) and the first working chamber (311) are stacked up and down.

4. The ultrasonic patch for internal human body treatment according to claim 3, characterized in that: The driving coil (334) is arranged on the partition sheet (36), and the sliding block (332) is arranged on the shell cover (35).

5. The ultrasonic patch for internal human body treatment according to claim 1, characterized in that: Sensors (4) electrically connected to the circuit board (342) are also provided at both ends of the bottom shell (32).

6. The ultrasonic patch for internal human body treatment according to claim 1, characterized in that: Transition slopes (321) are also provided on the four sides of the bottom shell (32).

7. The ultrasonic patch for internal human body treatment according to claim 1, characterized in that: The biomaterial bottom layer membrane (1) and the biomaterial surface layer membrane (2) are also respectively provided with a plurality of air permeable holes (20).

8. The ultrasonic patch for internal human body treatment according to claim 1, characterized in that: An adhesive layer (5) is also provided on the bottom surface of the biomaterial bottom layer membrane (1), and a release paper (6) is also provided on the bottom surface of the adhesive layer (5).

Images